Literature DB >> 8455066

Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus intravenous infusion.

A Hodozuka1, K Sako, H Nakai, M Tomabechi, N Suzuki, Y Yonemasu.   

Abstract

We observed the tissue delivery of a novel water-soluble nitrosourea, 1-(2-chloroethyl)-3-(methyl-alpha-D-glucopyranos-6-yl)-1-nitros our ea (MCNU) in rats bearing experimental brain tumors by conducting autoradiography on all. Prior to this study, the development of a streaming phenomenon was ascertained (and thus finding the optimum velocity for intra-arterial infusion) by 14C-iodoantipyrine (IAP) autoradiography. Furthermore, a single pass extraction value of MCNU was measured. At an arterial infusion rate of 0.2 ml/min., the streaming phenomenon was recognized but the tracer was fairly evenly distributed at a rate of 1.0 ml/min. On the other hand, the single pass extraction value for MCNU was 0.18 +/- 0.036 (mean +/- S.D., n = 3, under pentobarbital anesthesia). It was suggested that MCNU is very unlikely to be transported into the normal rat brain. We conducted 14C-MCNU autoradiography to observe tissue distribution of MCNU following its intra-arterial and intravenous infusions in a brain tumor model using rats. The normal side (the side where no infusions were given) and the cerebral cortex at the side affected by the tumor (the side where the infusion was given) showed hardly any uptake of 14C-MCNU in both the intra-arterial and intravenous infusion groups. The tumorous section was divided into the periphery and the center to measure tissue concentration of the tracer in each section. Compared against the cortical section, the periphery and the center showed significant increases in the concentration (approximately 11 to 15 times and 3 to 7 times, respectively, the figure for the cortical region) for both the intra-arterial and intravenous groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8455066     DOI: 10.1007/bf01050267

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  35 in total

1.  The uptake, distribution, and antitumor activity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the murine glioma.

Authors:  V A Levin; W R Shapiro; T P Clancy; V T Oliverio
Journal:  Cancer Res       Date:  1970-10       Impact factor: 12.701

2.  The permeability of brain capillaries to non-electrolytes.

Authors:  C Crone
Journal:  Acta Physiol Scand       Date:  1965-08

3.  Intra-arterial ACNU therapy for malignant brain tumors. Experimental studies and preliminary clinical results.

Authors:  J Yamashita; H Handa; Y Tokuriki; Y S Ha; S I Otsuka; K Suda; W Taki
Journal:  J Neurosurg       Date:  1983-09       Impact factor: 5.115

4.  Distribution of radiolabeled 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitros ourea hydrochloride in rat brain tumor: intraarterial versus intravenous administration.

Authors:  K Yamada; Y Ushio; T Hayakawa; N Arita; T Y Huang; M Nagatani; N Yamada; H Mogami
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

5.  Carotid artery injections in 40- to 99-g Fischer rats: technical note and evaluation of blood flow by various injection techniques.

Authors:  D E Bullard; S C Saris; D D Bigner
Journal:  Neurosurgery       Date:  1984-04       Impact factor: 4.654

6.  Hemorrhagic encephalitis produced by selective non-occlusive intracarotid BCNU injection in dogs.

Authors:  M F Omojola; A J Fox; R N Auer; F V Viñuela
Journal:  J Neurosurg       Date:  1982-12       Impact factor: 5.115

7.  Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.

Authors:  H S Greenberg; W D Ensminger; W F Chandler; P B Layton; L Junck; J Knake; A K Vine
Journal:  J Neurosurg       Date:  1984-09       Impact factor: 5.115

8.  A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II.

Authors:  M Suzuki; K Hori; I Abe; S Saito; H Sato
Journal:  J Natl Cancer Inst       Date:  1981-09       Impact factor: 13.506

9.  Biologic activity of MCNU: a new antitumor agent.

Authors:  S Sekido; K Ninomiya; M Iwasaki
Journal:  Cancer Treat Rep       Date:  1979-06

10.  Ocular toxicity associated with high-dose carmustine.

Authors:  B J Shingleton; D C Bienfang; D M Albert; W D Ensminger; W F Chandler; H S Greenberg
Journal:  Arch Ophthalmol       Date:  1982-11
View more
  2 in total

1.  Intra-arterial Chemotherapy for Malignant Tumors of Head and Neck Region Using Three Types of Modified Injection Method.

Authors:  T Kumagai; N Takeda; S Fukase; H Koshu; A Inoue; Y Ibuchi; Y Yoneoka
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

2.  Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model.

Authors:  N Takeda; M Diksic
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.